LILLY ASIA VENTURES
Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Lilly Asian Ventures invests in promising life science companies with strong management teams and innovative technology and/or business models. Their initial focus will be primarily on opportunities in China, although they will consider investment opportunities elsewhere in east and south Asia.
LILLY ASIA VENTURES
Social Links:
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
2008-01-01
Status:
Active
Contact:
+86 21 2316 9588
Email Addresses:
[email protected]
Technology used in webpage:
SSL By Default ASP.NET IIS DigiCert SSL ASP.NET 4.0 IIS 8 Encryption Everywhere China Telecom
Similar Organizations
ARCH Venture Partners
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Wisconsin Investment Partners
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-02 | Neukio Biotherapeutics | Lilly Asia Ventures investment in Series A - Neukio Biotherapeutics | 50 M USD |
| 2022-07-04 | ClinChoice昆翎 | Lilly Asia Ventures investment in Series E - ClinChoice昆翎 | 150 M USD |
| 2022-06-02 | ProfoundBio | Lilly Asia Ventures investment in Series A - ProfoundBio | 70 M USD |
| 2022-04-07 | Rona Therapeutics | Lilly Asia Ventures investment in Series A - Rona Therapeutics | 33 M USD |
| 2022-03-14 | IMPACT Therapeutics | Lilly Asia Ventures investment in Series D - IMPACT Therapeutics | N/A |
| 2022-02-28 | GluBio Therapeutics | Lilly Asia Ventures investment in Series A - GluBio Therapeutics | 50 M USD |
| 2022-02-15 | ArriVent Biopharma | Lilly Asia Ventures investment in Series A - ArriVent Biopharma | 69 M USD |
| 2022-02-08 | Pilot Biotechnology | Lilly Asia Ventures investment in Series C - Pilot Biotechnology | 100 M CNY |
| 2022-01-06 | Virtue Diagnostics | Lilly Asia Ventures investment in Series B - Virtue Diagnostics | 100 M USD |
| 2022-01-01 | ImmuneOnco Biopharma | Lilly Asia Ventures investment in Series C - ImmuneOnco Biopharma | 100 M USD |
More informations about "Lilly Asia Ventures"
Lilly Asia Ventures - Crunchbase Investor Profile
Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Lilly Asian Ventures invests in promising life science companies with strong management …See details»
Lilly Asia Ventures - Investments, Portfolio & Company Exits
Nov 19, 2024 · Lilly Asian Ventures is an investment firm that invests in promising life science companies.See details»
Lilly Asia Ventures investment portfolio | PitchBook
May 30, 2024 · Founded in 2008, Lilly Asia Ventures is a corporate venture capital arm of Eli Lilly based in Shanghai, China. The firm prefers to invest in seed-stage, early-stage, and later-stage companies.See details»
Lilly Asia Ventures - Funding, Financials, Valuation & Investors
Feb 14, 2019 · Lilly Asian Ventures is an investment firm that invests in promising life science companies.See details»
Lilly Asia Ventures - ImpactSpace
Oct 6, 2017 · Lilly Asia Ventures (LAV) is a healthcare focused venture capital and private equity firm based in Shanghai and Hong Kong. LAV's investment strategy is industry specific but stage agnostic. Major coverage areas include …See details»
Lilly Asia Ventures I: Fund Performance - PitchBook
May 30, 2013 · Lilly Asia Ventures I is a venture capital fund managed by Lilly Asia Ventures. The fund is located in Shanghai, China and invests in China. The fund targets investments in the …See details»
Lilly Asia Ventures - Private Equity International
Founded in 2008, Lilly Asia Ventures is a biomedical venture capital firm that focuses on investments primarily in biopharmaceuticals, human therapeutics, and medical devices across …See details»
Lilly Asia Ventures Investor Profile: Investments, Portfolio & Exits
Lilly Asia Ventures, founded in 2008 and headquartered in Shanghai, is a life sciences and healthcare sector focused venture capital firm, focusing predominantly on biopharmaceutical, …See details»
Lilly Asia Ventures eyes AI, metabolic disease …
Jun 19, 2019 · Lilly Asia Ventures, backed by Eli Lilly and Co., is eyeing artificial intelligence-driven drug discovery, metabolic disease therapies and other investment opportunities. Roughly 75% of the companies the Shanghai-based …See details»
Lilly Asia Ventures Leads USD100m Round for Shanghai’s Dizal …
Aug 20, 2020 · Lilly Asia Ventures led a USD100m round in Shanghai-based Dizal Pharma, a joint venture between state-owned SDIC Fund Management, Swedish drugmaker AstraZeneca, …See details»
ProfoundBio Announces Completion of More Than $55 million …
Jul 12, 2021 · WOODINVILLE, Wash. and SUZHOU, China, July 12, 2021 /PRNewswire/ -- ProfoundBio announced the closing of a $55+ million Series A financing round led by Lilly Asia …See details»
Lilly Asia Ventures Portfolio Companies - Crunchbase
Lilly Asian Ventures is an investment firm that invests in promising life science companies. This list of organizations invested in by Lilly Asia Ventures provides data on their funding history, …See details»
Kirkland Represents Lilly Asia Ventures in ... - Kirkland & Ellis LLP
Feb 8, 2021 · Kirkland advised Lilly Asia Ventures (LAV), a leading biomedical venture capital firm, in the one and final closing of its sixth USD life sciences funds, LAV Fund VI, L.P. and …See details»
Lilly Asia Ventures Closes Fifth Fund at USD750 Million, Joins …
China-focused life sciences investment fund manager Lilly Asia Ventures has closed LAV Biosciences Fund V at its hard cap of USD750 million. Investors in the fund include US-based …See details»
Lilly Asia Ventures closes $750M biosciences fund | PitchBook
Feb 20, 2019 · Lilly Asia Ventures has closed its latest flagship biosciences fund on $750 million, as first reported by AVCJ. Based in Shanghai with offices in Hong Kong and Menlo Park, the …See details»
Lilly Asia Ventures - Contacts, Employees, Board Members
Lilly Asian Ventures is an investment firm that invests in promising life science companies.See details»
Lilly Asia Ventures Reaches USD1.35b Final Close for Health Care …
Feb 3, 2021 · Lilly Asia Ventures has reached a USD1.35b final close for its latest health care fund, with USD900m raised for the main pool and an additional USD450m raised for an …See details»
OrbiMed, Lilly Asia Ventures chip into ADARx's $75M round to …
Sep 10, 2021 · OrbiMed Advisors and Lilly Asia Ventures are two key players pouring money into RNA-targeting technology via ADARx Pharmaceuticals’ $75 million series B round. The …See details»
Lilly Asia Ventures raises $1.35b for healthcare funds - AVCJ
Nov 10, 2023 · Lilly Asia Ventures (LAV) has raised $1.35 billion for its latest healthcare fund, having introduced a $450 million opportunity vehicle that sits alongside a core pool of $900 …See details»
Judith Li - Partner @ Lilly Asia Ventures - Crunchbase
Judith J. Li is a Partner at Lilly Asia Ventures (LAV), based in Hong Kong / Shanghai and focused on early and growth stage investments across biopharmaceuticals, medical devices, and …See details»